#Baxter International Plasma Fractionation Market Shares | Explore Tumblr posts and blogs

gauricmi · 7 months ago

Text

Global Quick E-Commerce (Quick Commerce) Market Driving Growth with Rising Urbanization

The global quick e-commerce market has witnessed substantial growth over the past few years owing to the growing preference for fast delivery of products among consumers. Quick commerce involves delivering groceries and daily essential items to customers within a fraction of an hour from placing the order online. Rising urbanization and increasingly busy lifestyles have continued to drive demand for quick and hassle-free online shopping. An ever growing young population and improved internet penetration are also contributing to the growth of the quick e-commerce model globally. The Global quick e-commerce (quick commerce) market is estimated to be valued at US$ 44.81 billion in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Quick Commerce Market Growth are Shire Plc., CSL Limited, Octapharma AG, LFB S.A., Biotest AG, Grifols, S.A., SK Plasma Co., Ltd., Baxter International Inc., Green Cross Corporation, and Fusion Health Care Pvt. Ltd., among others. These major players are focusing on adopting growth strategies such as collaborations, mergers & acquisitions, geographical expansions to garner more market shares. The key opportunities in the global quick e-commerce market include growing penetration of smartphones and ease of online ordering. Emergence of startups focusing on hyperlocal deliveries is further enhancing customer experience. The global expansion of the quick e-commerce market is driven by growing foreign direct investments from key technology players. Quick commerce platforms are expanding operations to new geographies characterized by growing urbanization such as Asia Pacific and Middle East regions. Market drivers Rising urbanization is one of the key drivers of the global quick e-commerce market. The increasing population residing in urban areas prefer online shopping owing to their busy lifestyles and lack of time for shopping. Growing preference for fast, reliable and hassle-free delivery of products is further expected to drive the quick commerce model.

PEST Analysis Political: The growing acceptance of digital commerce and lesser stringent regulations are supporting the growth of the global quick e-commerce market. However, data privacy laws and regulations can impact the market. Economic: The market is witnessing growth due to rising disposable incomes, improved internet penetration, and higher adoption of smartphone usage globally. Availability of diverse products at affordable prices is augmenting the demand. Social: Changing customer preferences towards instant gratification and seamless shopping experience are fueling the adoption of quick commerce solutions. Customers especially in densely populated cities prefer instant delivery over waiting for several hours. Technological: Investments in advanced technologies including AI, ML and automation are enabling companies to optimize delivery operations and provide enhanced customer experience through features like real-time tracking and personalized recommendations. Blockchain can be explored to build trust in the supply chain. In terms of value, the quick e-commerce market in Asia Pacific region is concentrated majorly, led by countries like China, India and Japan. In these densely populated countries with rising middle class, quick commerce is solving the issue of accessibility and availability of products. The quick e-commerce market is witnessing fastest growth in North America region. Evolving customer demands and expanding brick-and-mortar stores of companies delivering groceries, food and other daily essentials within an hour in major cities are supporting the market growth. Established logistics and road infrastructure also enables fast delivery of products.

Get More Insights On This Topic: Global Quick E-Commerce Market

#Global Quick Commerce Market Growth #Global Quick Commerce Market #Quick Commerce Market Size #Quick Commerce Market Share #Quick Commerce #Smart Technologies

0 notes

rohans18 · 1 year ago

Text

North America Plasma Fractionation Market Demands, Analysis, Size, Trends, Revenue by 2028

North America Plasma Fractionation Market, By Product Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato- Oncology, Rheumatology and Others), Processing Technology (Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration), Mode (Modern Plasma Fractionation and Traditional Plasma Fractionation), End User (Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others) , Country (Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, and Rest of North America) Industry Trends and Forecast to 2028.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via North America Plasma Fractionation marketing report. The report has a lot to offer to both established and new players in the North America Plasma Fractionation industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international North America Plasma Fractionation market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Some of the major players operating in the plasma fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, LFB SA, Green Cross Corp., Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, Bharat Serums and Vaccines Limited (BSV), Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd., Japan Blood Products Organization and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/north-america-plasma-fractionation-market

With the help of credible North America Plasma Fractionation market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging North America Plasma Fractionation market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the North America Plasma Fractionation Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

0 notes

ken-research-market-research · 5 years ago

Photo

Global Plasma Fractionation Market Research Report And Outlook: Ken Research Buy Now The report covers the analysis and forecast of global plasma fractionation market as well as regional level.

0 notes

ameymeti2001 · 2 years ago

Text

Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022

The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Research®. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper the growth of plasmapheresis market during the forecast period.

Market Segmentation

Global plasmapheresis market is segmented by product type (instrument and disposables), by technology (membrane filtration and centrifugation), by applications (therapeutic plasmapheresis and source plasma collection), by end user (biopharmaceutical companies, hospitals & clinics, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Source plasma collection/donor plasmapheresis segment dominates the global plasmapheresis market and is also expected to increase significantly in the next 5-10 years. The large share of this segment is mainly attributed to increasing demand of source plasma from plasma fractionation industry and rising demand for plasma for transfusion in a patient with various diseases.

Geographic Overview

Geographically, the global plasmapheresis market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global plasmapheresis market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher adoption of plasmapheresis for source plasma collection in the U.S. & Canada, increasing incidence of autoimmune disorders, well-established healthcare system, and favorable reimbursement in the U.S. for TPE procedures performed in hospitals. However, Asian countries are slated to register the fastest growth during the forecast period, owing to the rising healthcare spending, rising living standards, increasing awareness about plasmapheresis procedure, and growing plasma fractionation industry.

Key players

The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China).

Scope of the Report:

Plasma Fractionation Market, by Product

Immunoglobulins

Intravenous Immunoglobulins (IVIg)

Subcutaneous Immunoglobulins (SCIg)

Intramuscular Immunoglobulins (IMIg)

Coagulation Factors

Albumin

Protease Inhibitors

Other Products

Note: Other plasma-derived products include fibrin, sealant, and plasma

Plasma Fractionation Market, by Application

Immunology

Hematology

Neurology

Critical Care

Hematology-oncology

Rheumatology & Orthopedics

Other Applications

Note: Other applications include the management of respiratory diseases and wound healing.

Plasma Fractionation Market, by End User

Hospitals & Clinics

Clinical Research Laboratories

Academic & Research Institutes

Plasma Fractionation Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific

China

Japan

India

Australia

Indonesia

Vietnam

Thailand

Malaysia

Rest of Asia-Pacific (RoAPAC)

Latin America

Brazil

Mexico

Columbia

Peru

Rest of Latin America (RoLATM)

Middle East & Africa

South Africa

Rest of Middle East & Africa

Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022

0 notes

newsupdate-1 · 3 years ago

Text

Intravenous Immunoglobulin Market Size, Growth, Emerging Trends And Forecast

The most recent analysis on the Intravenous Immunoglobulin market provides a comprehensive review of all the important factors expected to drive market growth, including major drivers, constraints, market share, industry volume, recent trends, major breakthroughs, emerging opportunities, and future scope. The report's most crucial outcome for new market entrants includes a market-specific study, successful working strategies, key developments in the industrial sector, and major activities of leading players to persist in the market. This comprehensive research report includes a full market analysis as well as a market expert's opinion from the standpoint of the current market position and future projections.

Get Sample Copy of This Research Report: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

Immunoglobulins (IGs) are glycoproteins that are formed in the blood plasma in response to the antigens (Ag), which are considered as a foreign material to the host system. IGs are highly composite objects and precise in their nature. They are achieved from blood by fractionation procedure and filtered fo non-therapeutic as well as therapeutic applications. In therapeutics, they are administered intravenously for the treatment of several immunodeficiency.

Competitive Landscape of Intravenous Immunoglobulin Market

The prominent players present in the market are: (Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc.).

Market Segmentation

The study divides the Intravenous Immunoglobulin market into several parts to make it easier to understand the market dynamics. The major shareholder, higher revenue-generating, and dominating segments that are major drivers for the growth of the target market are covered in this section of the report. Players will need such analysis to determine the actual scope of the futuristic outlook and the potential for increased revenue.

Regional Analysis

The market research also sheds light on the regional analysis of the global Intravenous Immunoglobulin market, as well as a detailed examination of the different factors that enable specific regional markets to dominate the industry. The report forecasts total sales growth in several regions, as well as market development at the country level. The report's regional market study will aid readers in comprehending market reach in various regions. This section of the research will help players find untapped potential markets and extend their business in these lucrative regions to expand their customer base.

Access Full Report: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market

Reasons to Purchase this Report

· Analysis at the domestic and country-level that sheds light on the demand and supply aspects that are largely driving the Intravenous Immunoglobulin market's growth.

· A competitive landscape that includes firm profiles with essential financial data, a SWOT analysis, product offerings, recent developments, and strategies used.

· Comprehensive market analysis, including key drivers, restraints, growth rate, current trends, and potential prospects.

· Market segmentation analysis, which includes both quantitative and qualitative research, as well as the impact of policy and economic factors.

Customization of the Report

The report on the target market can be customized as per your specific requirements to fulfill the desired goals. Please get in touch with our team to get access to the most authentic report on the market. https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-customization

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

udaycmi · 3 years ago

Link

The global intravenous immunoglobulin market size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research published by Polaris Market Research

Get Sample copy of this report: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

The global intravenous immunoglobulin market is segmented on the basis of Application and geography. On the basis of application, the global Intravenous Immunoglobulin Market is categorized into Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP). In 2017, Hypogammaglobulinemia is estimated to dominate the application segment. The dominancy is attributed to the growing global occurrences of primary immunodeficiency diseases (PID). It is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). According to the Centers for Disease Control and Prevention (CDC) in 2012, the global occurrence rate of hypogammaglobulinemia was around 2 per 100,000 populations moreover, the number of people suffering this type of disease are estimated to increase during the forecast period. Growing occurrence of immunodeficiency disorders associated with the high implementation of IVIG therapies is expected to drive the segment growth significantly.

Some major key players in global intravenous immunoglobulin market include Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare among others.

Request For Discount: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

marketresearchhealthcarefuture · 4 years ago

Text

Blood Plasma Derivatives Market Analysis By Size, Share, Segments and Regional Trends 2027

Market Research Future (MRFR) predicts that the global blood plasma derivatives market will attain the valuation of USD 58.2 billion by 2023, after reaching USD 30.5 billion in 2016. The market can achieve a CAGR of 7.52% during the forecast period (2017-2023), says MRFR.

Esteemed Players

The esteemed players in the worldwide blood plasma derivatives market include CSL Limited (Australia), Baxter International Inc. (U.S), SK Plasma (Korea), Grifols (Germany), Fusion Healthcare (India), and others.

Players like Bain Capital (U.S), Biotest AG (Germany), Octapharma AG (Germany), are also operating in the market.

Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1325

Growth Boosters and Key Barriers

Blood plasma refers to blood’s liquid component that comprises the extracellular matrix. It plays a big part in maintaining electrolyte as well as osmotic balance, and also helps prevent infection and blood disorders within the body. It contains primarily water coupled with various other components including dissolved proteins, immunoglobulin, clotting factors, glucose, hormones, and electrolytes.

Plasma derivatives can be described as the concentrates of certain proteins that need pooling of plasma from a huge number of donors. It requires over hundred plasma donations to generate enough immunoglobulin to treat an immune deficient patient for at least a year. This factor presents numerous lucrative opportunities for technological advancements for elevating plasma-derived products’ production.

Boost in demand for blood plasma derivatives has been noted on account of the massive patient pool and the lack of alternative treatments. This is believed to add to the strength of the market to a large extent. To elaborate, there is no definite cure for hemophilia at present, wherein the patient requires a lifelong infusion of plasma-derived products. Other crucial factors that have a hand in the market growth include the surge in disease awareness as well as education, rising commitment to research, and organized network of donor centers. On a different note, the high cost of treatment could act as an obstacle in the market growth.

March 2019

GCAM, Inc. has added a set of new blood plasma collection centers in Texas (U.S.) to its existing infrastructure. With these additions, the company now owns 10 plasma donation centers across the country.

Intended Audience

Blood Plasma Derivatives Companies

Research and Development (R&D) Companies

Medical Research Laboratories

Diagnostic centers

Blood transfusion centers

Academic Medical Institutes and Universities

Market Segmentation

The worldwide Blood Plasma Derivatives Market has been segmented on the basis of type, application, and end-users.

The blood plasma derivatives market, depending on the type, covers albumin, anti-thrombin, intravenous immunoglobulin (IVIG), fresh frozen plasma (FFP) and others. Other types include Factor VII, Factor IX, and Alpha 1 proteinase inhibitor concentrate.

With respect to the application, the market caters to Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others. Other applications covered by the report are Von Willebrand disease.

End users, as per the report, are hospitals, clinics, diagnostic centers, blood transfusion centers, and others.

Regional Insight

The worldwide blood plasma derivatives market is split into the main regions of Europe, Asia Pacific Middle East & Africa as well as North America.

Experts predict that the North America blood plasma derivatives market will surge at a CAGR of 4.25% in the coming years. The regional market is expected to increase from the value of USD 20 billion in 2016 to USD 35.50 billion by 2023. The region is noted for early approval of plasma derivatives products and rising number of fractionation plants, which works in favor of the market. The mounting awareness level pertaining to the use of plasma derivatives for infectious diseases could be another critical factor boosting the market.

Europe is reckoned to be the second-most profitable market for blood plasma derivatives, expected to rise at a CAGR of 3.8% in the years ahead. Exhaustive research on safe blood transfusion within the healthcare centers and numerous research laboratories are the chief reasons for the lucrative market in the region. In addition to the expanding geriatric population in the region, the rise in awareness about blood & plasma donation is perceived to augur well with the market in the ensuing years.

With the fastest-growth in the global blood plasma derivatives market, Asia Pacific will benefit from the prevalence of life-threatening diseases and the high awareness levels in the region. India has been identified as the strongest contender with the quickest growth rate in the region.

The market in Middle East and Africa is presumed to demonstrate consistent growth. Southern and Eastern Africa note the highest number of HIV cases, which accounts for almost 19 million people. The number of HIV cases are expected to increase rapidly in other parts of Middle East and Africa as well. These factors are expected to elevate the demand for blood plasma derivatives in the region in the years to come.

Get More Information on Blood Plasma Derivatives Market Research Report- Global Forecast To 2023 @ https://www.marketresearchfuture.com/reports/blood-plasma-derivatives-market-1325

Scope of Report

The report for Blood Plasma Derivatives market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

0 notes

karishmamulani · 4 years ago

Text

Intravenous Immunoglobulin Market Share Forecasts, Regional Trends & Growth Drivers

The global intravenous immunoglobulin market size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research published by Polaris Market Research

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

Moreover, according to the U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from PID globally. Rising occurrences of these immune diseases is anticipated to bolster the demand for intravenous immunoglobulin treatments during the forecast period. The demand for IVIG treatments for the primary and acquired immunodeficiency disorder is growing as it is the only available as well as most effective treatment option. Moreover, inactive lifestyle behaviors, including intake of saturated fats, sugars and salts, less physical actions, and high alcohol intake have led to the surge in the occurrence of such diseases. Increasing occurrence of such lifestyle related disease including antibody deficiency disorders and obesity are the factors anticipated to drive the global intravenous immunoglobulin market growth.

Get Discount Offer: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-discount-pricing

#Intravenous Immunoglobulin Market #Intravenous Immunoglobulin Market size #Intravenous Immunoglobulin Market share

0 notes

mathewwon802 · 5 years ago

Text

Blood Plasma Market Executive Summary, Introduction, Sizing, Analysis and Forecast To 2027

Global Blood plasma Market, by Blood Plasma Types (Immunoglobulin (Intravenous Immunoglobulin, Subcutaneous Immunoglobulin, other Immunoglobulin Type), Albumin, Hyperimmune, Coagulation Factor Concentrates, & Other Plasma Fractionation Products), By Application (Immunology, Oncology, Pulmonology, Rheumatology, Transplantation, Neurology, Haematology, & Other Applications), By End User (Hospitals, Clinics, Research Laboratories, Academic Institutes) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2019 and 2027.

For requesting free sample related to our latest study on global blood plasma market, visit : https://meridianmarketconsultants.com/requst?rid=3284

As per the report, Plasma is a component with a yellowish color, which helps to hold blood cells. Blood plasma mainly carries cells and proteins and helps to flow it throughout the body and also helps to balance body temperature and blood pressure. It is used for the treatment of autoimmune disorders and many other health problems as an ingredients in various medical products.

Meridian Market Consultants study indicates that in 2018, immunoglobulin segment in blood plasma types is accounted to hold largest market share in comparison to other segment and expected to maintain high growth rate during the forecast period, owing to increasing demand of immunoglobulin in plasma derived market mainly in the U.S.

Also increase in the prevalence of hemophilia is one of the major factor that is expected to drive the growth of market around the globe. Treatment of hemophilia with factor concentrates is required as a base forever or appendage undermining draining scenes and for medical procedure. While treatment with plasma or cryoprecipitate is likewise conceivable, wellbeing can't be guaranteed. The ideal is prophylactic treatment to forestall joint harm, dismalness and mortality. On the off chance that untreated, demise regularly happens in adolescence. Absence of treatment moreover brings about devastating arthropathy. Treatment with hazardous items dangers HIV and hepatitis disease. Kids who don't approach treatment are for the most part unfit to finish instruction because of successive serious draining scenes, also, this will oblige their capacity to pick up work, raise and bolster a family and contribute completely to society. Whatever the degree of treatment item accessibility in a nation, use ought to be moved toward a national premise.

To know the latest insights, qualitative data, trends, quantitative data, and more related to global blood plasma market, visit : https://meridianmarketconsultants.com/global-blood-plasma-market

Furthermore, Meridian Market Consultants (MMC) Study identifies that, in 2018, North America is accounted to hold the largest market share in comparison to other regions and expected to maintain its dominance throughout the forecast period, owing to the presence of key players in the region and availability of advance healthcare structure in comparison to other regions.

MMC Study identifies some of the key participating players in Blood plasma market globally are Adma Biologics, Baxter International, TCS Biosciences, Cerus Corp., Octopharma AG, CSL Ltd., China Biologic Products, Baxter International Inc., Grifols S.A., Biotest AG, Kedrion S.p.A., Shire, and Sanquin., and others.

Read detail News @ : https://meridianmarketconsultants.com/pressrelese/global-blood-plasma-market

About Meridian Market Consultants:

Meridian Market Consultants (MMC) is committed to provide deep insights that serve as creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Meridian Market Consultants (MMC)

13121, Louetta Road,

#440, Cypress, Texas 77429

United States

Tel: +1-(281)-619-8646

For Sales Queries: [email protected]

#business consultant #business forecast #market forecast #market analysis #market research report #market growth #market trends #business analysis

0 notes

kdmarketresearch · 5 years ago

Text

Albumin Market Likely to Acquire Rapid Momentum as Technology Advances 2016-2023

KD Market research launches a new market research report on the Albumin Market. The study covers a detailed in-depth analysis of the global market along with the regional and country level analysis. The study also delivers a complete analysis about the major & niche players of Albumin Market which includes profiling of Grifols, S.A., Octapharma AG, China Biologic Products, Inc., Ventria Bioscience,. Shire Plc, CSL Limited, Albumedix Ltd., Merck KGaA , Thermo Fisher Scientific, Baxter International Inc.. Albumin is globular protein found in blood plasma. Serum albumin is the most abundant plasma protein, constituting around 50% of human plasma protein. Albumin is obtained from plasma fractionation process where human serum albumin and bovine serum albumin is most widely used. Recombinant albumin is produced using recombinant techniques in rice plants, yeast species, and other cell lines. Albumin is used as blood volumizer and is employed in the treatment of various diseases including surgical blood loss, shock, burns, trauma, chronic liver disease, hypovolemia, hemorrhage, acute liver failure, hypoalbuminemia, and acute respiratory distress syndrome.

Request sample Copy@ https://www.kdmarketresearch.com/sample/3208

The global albumin market was valued at $5,381 million in 2016, and is projected to reach $10,305 million at a CAGR of 9.6% from 2017 to 2023. Increase in prevalence of rare diseases, shocks, trauma, burns, and other fatalities is the major factor that contributes toward the growth of the albumin market. Moreover, other factors that fuel the market growth include increase in adoption of albumin products, growth in awareness about recombinant albumin products, and rise in non-therapeutic application of albumin as an excipient and drug formulating agent. However, stringent governmental regulations and risks of side effects associated with the use of albumin-based therapy impede the market growth. Conversely, development of cost-effective therapeutics through large scale production and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market.

The global albumin market is segmented into product, application, and region. Based on product, the market is divided into human serum albumin, bovine serum albumin, and recombinant albumin. The applications covered in the study include therapeutics, drug formulation & vaccine, component of media, and other applications. Based on region, it is analyzed for North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

-The study provides an in-depth analysis of the global albumin market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.

-Comprehensive analysis of factors that drive and restrict the market growth is provided.

-Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.

-Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key market segments:

By Product

-Human Serum Albumin -Bovine Serum Albumin -Recombinant Albumin

By Application

-Therapeutics -Drug Formulation & Vaccine -Component of Media -Other Applications

By Region

-North America -U.S. -Canada -Mexico -Europe -Germany -France -UK -Italy -Spain -Rest of Europe -Asia-Pacific -Japan -China -India -Australia -South Korea -Rest of Asia-Pacific -LAMEA -Brazil -Saudi Arabia -South Africa -Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

-Grifols, S.A. -Octapharma AG -China Biologic Products, Inc. -Ventria Bioscience -Shire Plc -CSL Limited -Albumedix Ltd. -Merck KGaA -Thermo Fisher Scientific -Baxter International Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

-Biotest AG -Medxbio Pte Ltd -Mitsubishi Tanabe Pharma Corporation -Kedrion Biopharma, Inc. -HiMedia Leading BioSciences Company -Celgene Corporation

Browse full Research Report with toc@ https://www.kdmarketresearch.com/report/3208/albumin-market-amr

Table of Content

CHAPTER 1: INTRODUCTION

1.1. Report description 1.2. Key benefits for stakeholders 1.3. Key market segments 1.4. Research methodology

1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope 3.2. Key findings

3.2.1. Top investment pockets

3.3. Market share analysis, 2016 3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in prevalence of rare diseases and various life-threatening conditions 3.4.1.2. Increase in demand for albumin 3.4.1.3. Growing preferences for recombinant albumin 3.4.1.4. Rise in non-therapeutic application of albumin

3.4.2. Restraints

3.4.2.1. Stringent government regulations 3.4.2.2. Risks associated with albumin

3.4.3. Opportunities

3.4.3.1. Opportunities in emerging economies 3.4.3.2. Development of cost effective therapeutics through large scale production

3.4.4. Impact analyses

3.5. Government regulations 3.6. Patent analysis (2013-2018)

3.6.1. Patent analysis, by year 3.6.2. Patent analysis for year 2017, by country

CHAPTER 4: ALBUMIN MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Human serum albumin

4.2.1. Key market trends, growth factors and opportunities 4.2.2. Market size and forecast, by region 4.2.3. Market analysis, by country

4.3. Bovine serum albumin

4.3.1. Key market trends, growth factors and opportunities 4.3.2. Market size and forecast, by region 4.3.3. Market analysis, by country

4.4. Recombinant albumin

4.4.1. Key market trends, growth factors and opportunities 4.4.2. Market size and forecast, by region 4.4.3. Market analysis, by country

CHAPTER 5: ALBUMIN MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast (value)

5.2. Therapeutics

5.2.1. Market size and forecast, by region 5.2.2. Market analysis, by country

5.3. Drug formulation & vaccines

5.3.1. Market size and forecast, by region 5.3.2. Market analysis, by country

5.4. Component of media

5.4.1. Market size and forecast, by region 5.4.2. Market analysis, by country

5.5. Other applications

5.5.1. Market size and forecast, by region 5.5.2. Market analysis, by country

CHAPTER 6: ALBUMIN MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors and opportunities 6.2.2. North America albumin market, by country

6.2.2.1. U.S.

6.2.2.1.1. Market size and forecast, by product 6.2.2.1.2. Market size and forecast, by application

6.2.2.2. Canada

6.2.2.2.1. Market size and forecast, by product 6.2.2.2.2. Market size and forecast, by application

6.2.2.3. Mexico

6.2.2.3.1. Market size and forecast, by product 6.2.2.3.2. Market size and forecast, by application

6.2.3. North America market size and forecast, by product 6.2.4. North America market size and forecast, by application

6.3. Europe

6.3.1. Key market trends, growth factors and opportunities 6.3.2. Europe market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Market size and forecast, by product 6.3.2.1.2. Market size and forecast, by application

6.3.2.2. France

6.3.2.2.1. Market size and forecast, by product 6.3.2.2.2. Market size and forecast, by application

6.3.2.3. UK

6.3.2.3.1. Market size and forecast, by product 6.3.2.3.2. Market size and forecast, by application

6.3.2.4. Italy

6.3.2.4.1. Market size and forecast, by product 6.3.2.4.2. Market size and forecast, by application

6.3.2.5. Spain

6.3.2.5.1. Market size and forecast, by product 6.3.2.5.2. Market size and forecast, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Market size and forecast, by product 6.3.2.6.2. Market size and forecast, by application 6.3.2.6.3. Europe market size and forecast, by product 6.3.2.6.4. Europe market size and forecast, by application

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors and opportunities 6.4.2. Asia-Pacific market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Market size and forecast, by product 6.4.2.1.2. Market size and forecast, by application

6.4.2.2. China

6.4.2.2.1. Market size and forecast, by product 6.4.2.2.2. Market size and forecast, by application

6.4.2.3. India

6.4.2.3.1. Market size and forecast, by product 6.4.2.3.2. Market size and forecast, by application

6.4.2.4. Australia

6.4.2.4.1. Market size and forecast, by product 6.4.2.4.2. Market size and forecast, by application

6.4.2.5. South Korea

6.4.2.5.1. Market size and forecast, by product 6.4.2.5.2. Market size and forecast, by application

6.4.2.6. Rest of Asia-Pacific

6.4.2.6.1. Market size and forecast, by product 6.4.2.6.2. Market size and forecast, by application

6.4.3. Asia-Pacific market size and forecast, by product 6.4.4. Asia-Pacific market size and forecast, by application

6.5. LAMEA

6.5.1. Key market trends, growth factors and opportunities 6.5.2. LAMEA market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Market size and forecast, by product 6.5.2.1.2. Market size and forecast, by application

6.5.2.2. Saudi Arabia

6.5.2.2.1. Market size and forecast, by product 6.5.2.2.2. Market size and forecast, by application

6.5.2.3. South Africa

6.5.2.3.1. Market size and forecast, by type 6.5.2.3.2. Market size and forecast, by application

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Market size and forecast, by product 6.5.2.4.2. Market size and forecast, by application

6.5.3. LAMEA market size and forecast, by product 6.5.4. LAMEA market size and forecast, by application

CHAPTER 7: COMPANY PROFILES

7.1. Baxter International Inc.

7.1.1. Company overview 7.1.2. Company snapshot 7.1.3. Operating business segments 7.1.4. Product portfolio 7.1.5. Business performance

7.2. China Biologic Products Holdings, Inc.

7.2.1. Company overview 7.2.2. Company snapshot 7.2.3. Operating business segments 7.2.4. Product portfolio 7.2.5. Business performance

7.3. CSL Limited

7.3.1. Company overview 7.3.2. Company snapshot 7.3.3. Operating business segments 7.3.4. Product portfolio 7.3.5. Business performance

7.4. Grifols S.A. (Grifols International, S.A.)

7.4.1. Company overview 7.4.2. Company snapshot 7.4.3. Operating business segments 7.4.4. Product portfolio 7.4.5. Business performance 7.4.6. Key strategic moves and developments

7.5. Merck KGaA

7.5.1. Company overview 7.5.2. Company snapshot 7.5.3. Operating business segments 7.5.4. Product portfolio 7.5.5. Business performance 7.5.6. Key strategic moves and developments

7.6. Novozymes A/S (Albumedix Ltd.)

7.6.1. Company overview 7.6.2. Operating business segments 7.6.3. Product portfolio 7.6.4. Business performance

7.7. Octapharma AG

7.7.1. Company overview 7.7.2. Company snapshot 7.7.3. Operating business segments 7.7.4. Product portfolio 7.7.5. Business performance

7.8. Shire Plc. (Shire US, Inc.)

7.8.1. Company overview 7.8.2. Company snapshot 7.8.3. Operating business segments 7.8.4. Product portfolio 7.8.5. Business performance

7.9. Thermo Fisher Scientific Inc (Affymetrix, Inc.)

7.9.1. Company overview 7.9.2. Company snapshot 7.9.3. Operating business segments 7.9.4. Product portfolio 7.9.5. Business performance 7.9.6. Key strategic moves and developments

7.10. Ventria Bioscience

7.10.1. Company overview 7.10.2. Company snapshot 7.10.3. Operating product categories 7.10.4. Product portfolio

Request Exclusive Discount @ https://www.kdmarketresearch.com/discount/3208

About Us:

KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.

Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.

KD Market Research

150 State Street, Albany,

New York, USA 12207

Website: www.kdmarketresearch.com

Email id- [email protected]

More - https://kdmarketresearch.blogspot.com/

#Albumin market size #Albumin Market trends #Albumin Market news #Albumin Market Share #Albumin Market Analysis #Albumin Market Forecast

0 notes

omgsampada · 4 years ago

Link

The global intravenous immunoglobulin market size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research published by Polaris Market Research

Request for sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

The global intravenous immunoglobulin market majorly is driven by rising elderly population, increasing occurrence of immunodeficiency disorders, growing implementation of IVIG procedures and increasing usage of off-label indications. Increasing number of patients with immunodeficiency disease is the primary reason for the expansion of IVIG procedures. According to the World Health Organization (WHO), there are approximately 50 diverse Primary Immune Deficiency (PID) such as X-lined hypo-gamma-globulinemia, specific antibody deficiency and others. Moreover, according to the U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from PID globally. Rising occurrences of these immune diseases is anticipated to bolster the demand for intravenous immunoglobulin treatments during the forecast period. The demand for IVIG treatments for the primary and acquired immunodeficiency disorder is growing as it is the only available as well as most effective treatment option. Moreover, inactive lifestyle behaviors, including intake of saturated fats, sugars and salts, less physical actions, and high alcohol intake have led to the surge in the occurrence of such diseases. Increasing occurrence of such lifestyle related disease including antibody deficiency disorders and obesity are the factors anticipated to drive the global intravenous immunoglobulin market growth.

Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

rohans18 · 1 year ago

Text

Middle East and Africa Plasma Fractionation Market Expected High Growth in Coming Years

Global Middle East and Africa Plasma Fractionation Market, By Product Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato- Oncology, Rheumatology and Others), Processing Technology (Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration), Mode (Modern Middle East and Africa Plasma Fractionation and Traditional Middle East and Africa Plasma Fractionation), End User (Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others) , Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Middle East and Africa Plasma Fractionation marketing report. The report has a lot to offer to both established and new players in the Middle East and Africa Plasma Fractionation industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Middle East and Africa Plasma Fractionation market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Some of the major players operating in the Middle East and Africa Plasma Fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, Japan Blood Products Organization, China Biologic Products Holdings, Inc., LFB SA, Green Cross Corp., Shanghai RAAS, Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, KabaFusion, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Bharat Serums and Vaccines Limited (BSV), SK Plasma, Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-plasma-fractionation-market

With the help of credible Middle East and Africa Plasma Fractionation market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Middle East and Africa Plasma Fractionation market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Middle East and Africa Plasma Fractionation Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

0 notes

insightslice · 4 years ago

Text

Plasma Protein Therapeutics Market Trends, Analysis and Forecasts, 2020 – 2030

The plasma protein therapeutics market is highly competitive and is governed by stringent regulations worldwide. The plasma collection standards are high in the developed geographies and follows a strict regulatory framework to maintain operational quality. The fractionation process is monitored by the health authorities to prevent poor quality of plasma and ensure that the source plasma is not contaminated with infectious agent such as Parvovirus B, hepatitis A, B and C, and HIV. The plasma protein therapy cycle is complex and is strictly monitored to maintain process safety & efficacy, donor safety, biological license, compliance and pharmacovigilance. The demand for immunoglobulin is increasing significantly across the globe due to increasing incidences of the primary immunodeficiencies (PID). This has resulted in increased number of clinical applications such as autoimmune, and acute inflammatory disorders. The increasing demand for plasma protein therapeutics for treatment of autoimmune neurologic diseases, acute cardiomyopathy, multifocal motor neuropathy (MMN), hemolytic disease of the newborn, autoimmune mucocutaneous blistering diseases, and acute panautonomic polyneuropathy is the prime factor towards the growth of the global plasma protein therapeutics market.

Request For PDF Sample Report: https://www.insightslice.com/request-sample/344

North America contributed the largest share to the global plasma protein therapeutics market in 2019 owing to rising demand, expanding geriatric population, and availability of robust plasma donation infrastructure. The leading players across North America are inclined towards acquisition of small plasma donation centers to expand their service network and are investing significantly on the development of new plasma donation centers. This has intensified the competition in the market and is anticipated to benefit the patients suffering from plasma deficiency. Asia Pacific is anticipated to be the fastest growing market for plasma protein therapeutics during the forecast period. Increasing number of patients suffering from primary immunodeficiencies (PID) & hemophilia across the major countries, rising awareness regarding the plasma transplant solutions and expanding healthcare infrastructure are expected to bolster the plasma protein therapeutics market in Asia Pacific. Additionally, the government authorities are actively engaged in spreading awareness about plasma donation and are offering incentives to the donors, which is anticipated to support the growth of Asia Pacific plasma protein therapeutics.

The report titled “Plasma Protein Therapeutics Market – Global Market Share, Trends, Analysis and Forecasts, 2020-2030” offers market estimates for a period 2018 to 2030, wherein 2018 is historic period, 2019 is the base year, and 2020 to 2030 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global plasma protein therapeutics market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

Get TOC of Research Report: https://www.insightslice.com/request-toc/344

The global plasma protein therapeutics market is segmented based on product type, applications, and geography. Based on product type, the global plasma protein therapeutics market is segmented into immunoglobulin, albumin, plasma derived factor VIII, and others. Based on applications, the global plasma protein therapeutics market is segmented into hemophilia, idiopathic thrombocytopenic purpura, primary immunodeficiencies, and others. Based on geography, the global plasma protein therapeutics market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on plasma protein therapeutics products. Further, market share of prominent companies in the global plasma protein therapeutics market would also be estimated. The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the plasma protein therapeutics companies.

The global plasma protein therapeutics market study would take into consideration the participants engaged throughout the ecosystem of the market, along with their contribution. Product portfolio would focus on all the products under the plasma protein therapeutics business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global plasma protein therapeutics market.

Major players active in the global plasma protein therapeutics market include Baxter International Inc., Biotest Pharmaceuticals Corporation, China Biologic Products, Inc., CSL Behring, GRIFOLS, S.A, Kedrion S.p.A., Octapharma USA, Inc., and Shire Plc.

0 notes

ameymeti2001 · 2 years ago

Text

Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022

Market Segmentation

Geographic Overview

Key players

Scope of the Report:

Plasma Fractionation Market, by Product

Immunoglobulins

Intravenous Immunoglobulins (IVIg)

Subcutaneous Immunoglobulins (SCIg)

Intramuscular Immunoglobulins (IMIg)

Coagulation Factors

Albumin

Protease Inhibitors

Other Products

Note: Other plasma-derived products include fibrin, sealant, and plasma

Plasma Fractionation Market, by Application

Immunology

Hematology

Neurology

Critical Care

Hematology-oncology

Rheumatology & Orthopedics

Other Applications

Note: Other applications include the management of respiratory diseases and wound healing.

Plasma Fractionation Market, by End User

Hospitals & Clinics

Clinical Research Laboratories

Academic & Research Institutes

Plasma Fractionation Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific

China

Japan

India

Australia

Indonesia

Vietnam

Thailand

Malaysia

Rest of Asia-Pacific (RoAPAC)

Latin America

Brazil

Mexico

Columbia

Peru

Rest of Latin America (RoLATM)

Middle East & Africa

South Africa

Rest of Middle East & Africa

Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022

0 notes

udaycmi · 4 years ago

Link

The global intravenous immunoglobulin market size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research published by Polaris Market Research

Get Sample copy of this report: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

Request For Discount: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

marketresearchhealthcarefuture · 4 years ago

Text

Blood Plasma Derivatives Market Valuation Reach US$ 58.2 billion with a CAGR of 7.52%

The global blood plasma derivatives market is growing mainly due to the increasing demand for plasma derived products. According to a recent study report published by the Market Research Future, The global blood plasma derivatives market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Blood Plasma Derivatives Market Projected to Grow Radiantly by 2023; Asserts MRFR Unleashing Industry Forecast

Plasma is a fluid part of the blood that contains blood cells, and protein responsible for blood clotting. Plasma derivatives are obtained from specific plasma proteins by the process of fractionation. The derivatives are then solvent detergent-treated or heat-treated to kill certain viruses. The most common plasma derivative includes factor IX concentrate, factor VIII concentrate, anti-inhibitor coagulation complex (AICC), anti-thrombin III concentrate, immune globulins, Alpha 1-Proteinase inhibitor concentrate, albumin, and anti-thrombin III concentrate. Blood plasma derivative widely used clinically to treat various conditions such as hemophilia A, hemophilia B, HIV, hepatitis B, hepatitis C, thrombocytosis, and others.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/1325

Global Blood Plasma Derivatives Market – Competitive Analysis

Grigols (Spain), Baxter International Inc. (US), Octapharma AG (Switzerland), CSL Limited (Australia), Kedrion S.p.A (Italy), Bain Capital, LLC (US), Biotest AG (Germany), Fusion Healthcare (India), SK Plasma Co., Ltd. (South Korea) are some of the prominent players at the forefront of competition in the blood plasma derivatives market and are profiled in MRFR Analysis.

Global Blood Plasma Derivatives Market is currently dominated by few players.

Grigols is one of them by holding a strong share in the market. The company’s stronghold is largely attributed to its innovative and sustainable products. Grigols aoperates in three major divisions i.e. Bioscience, Diagnostic and Hospital. On November 17, 2017 Grigols received FDA approval for a new genetic test used to detect alpha-1 antitrypsin deficiency. On November 11, 2013, Grifols acquired blood transfusion testing unit of Novartis AG for USD 1.68 billion. In the year 2016, Grifols has also acquired NAT (Nucleic Acid Testing) donor screening unit of Hologic for USD 1,850 million.

Baxter is also one of the leading player in blood plasma derivatives market. Baxter International Inc., the US based biopharmaceutical company, operates in two major segments, i.e. Hospital Products and Renal. Baxter’s product Bebulin (Factor IX Complex) is specifically used for the prevention, of hemorrhagic episodes in case of hemophilia B. Bebulin may carry a risk of transmitting infectious agents, such as viruses and, Creutzfeldt‐Jakob disease (CJD) agent.

On July 27, 2017, Baxter International Inc. completed the acquisition of Claris Injectables Limited for approximately USD 625 million. The main motive of acquisition is the expansion of generic pharmaceuticals.

On June 06, 2017, ADMA Biologics, Inc., a biopharmaceutical company, has acquired therapy business unit of Biotest Pharmaceuticals. As a result of this, ADMA acquired two FDA approved products i.e. Nabi-HB™, and and BIVIGAM™.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/blood-plasma-derivatives-market-1325

Regional Analysis of Blood Plasma Derivatives Market:

Globally, Blood Plasma Derivatives market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa.

North America is the largest market for syringe and needle. The North American market for Blood Plasma Derivatives is expected to grow at a CAGR of 4.25% which is expected to reach at US$ 35.50 billion from US$ 20 billion in 2016 by the end of the forecasted period.

Awareness regarding use of plasma derivatives for patients suffering from infectious diseases drive this market in North America. Europe is the second-largest market for Blood Plasma Derivatives which is expected to grow at a CAGR of 3.8%. Extensive research on safe blood transfusion in healthcare organizations and research laboratories favor the growth of this market in Europe.

Whereas Asia Pacific is expected to be the fastest growing market for Blood Plasma Derivatives market. India is expected to be the emerging and fastest growing market. Demand for plasma derivatives for inactivation of HIV favor the demand of plasma derivatives in Asia-pacific. The market shows steady growth in Middle East and Africa.

Avail Discount at https://www.marketresearchfuture.com/check-discount/1325

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

0 notes